These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13196757)

  • 21. Muscular dystrophy associated with paroxysmal myoglobinuria and excessive excretion of ketosteroids.
    ACHESON D; McALPINE D
    Lancet; 1953 Aug; 265(6782):372-5. PubMed ID: 13085785
    [No Abstract]   [Full Text] [Related]  

  • 22. Pentosuria in neuromuscular disorders.
    DREW AL
    Am J Phys Med; 1955 Feb; 34(1):309-11; discussion 311-12. PubMed ID: 14361708
    [No Abstract]   [Full Text] [Related]  

  • 23. [Modifications in the elimination of creatine bodies in muscular dystrophy during vitamin B12 therapy].
    CORDA G
    Boll Soc Ital Biol Sper; 1952 Dec; 28(12):1935-7. PubMed ID: 13059130
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diphosphopyridin nucleotide in the urine in progressive muscular dystrophy].
    Kondo F; Abe E; Ikeda M; Mue S
    Iryo; 1967 Jul; 21(7):827-34. PubMed ID: 4295720
    [No Abstract]   [Full Text] [Related]  

  • 25. Observations concerning pentosuria and labile phosphate excretion in muscular dystrophy.
    ABEL FL; ROUTH JI; SHEPHERD JA; UTTERBACK RA
    Clin Chem; 1960 Apr; 6():98-114. PubMed ID: 13791433
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary kinins and histamine in urine of progressive muscular dystrophy.
    Nakahara M; Sakahashi H
    Sapporo Igaku Zasshi; 1966; 29(1):1-7. PubMed ID: 6006282
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current views of the pathogenesis of Erb's progressive muscular dystrophy, with special consideration of the excretion of all neutral C-17-ketosteroids].
    BECKMANN R
    Klin Wochenschr; 1952 May; 30(19-20):465-9. PubMed ID: 14928513
    [No Abstract]   [Full Text] [Related]  

  • 28. Occasional appearance of diphosphopyridine nucleotide in urine of patients with progressive muscular dystrophy.
    Kondo F; Abe E; Ikeda M; Mue S
    Tohoku J Exp Med; 1967 Feb; 91(2):191-9. PubMed ID: 4292997
    [No Abstract]   [Full Text] [Related]  

  • 29. [Melituria in basal conditions and after sugar overloading in subjects of pediatric age with progressive muscular dystrophy].
    Scorza P; Berni M
    Boll Soc Ital Biol Sper; 1967 Aug; 43(15):943-6. PubMed ID: 6060510
    [No Abstract]   [Full Text] [Related]  

  • 30. Paper chromatographic detection of sugars in normal and dystrophic human urines.
    HESS WC; WHITE AA
    Arch Biochem Biophys; 1956 Sep; 64(1):57-66. PubMed ID: 13363413
    [No Abstract]   [Full Text] [Related]  

  • 31. Creatine and creatinine in tissues and urine of mice with hereditary muscular dystrophy.
    KANDUTSCH AA; RUSSELL AE
    Am J Physiol; 1958 Sep; 194(3):553-6. PubMed ID: 13571426
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new method of isolation of urinary riboside].
    LEONE E
    Boll Soc Ital Biol Sper; 1955 Jun; 31(6):622-4. PubMed ID: 13269545
    [No Abstract]   [Full Text] [Related]  

  • 33. Human muscular dystrophy: elevation of urinary dimethylarginines.
    Lou MF
    Science; 1979 Feb; 203(4381):668-70. PubMed ID: 760213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
    Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical studies on muscular dystrophy. Serum and urine creatine, creatinine and aminoacids.
    el-Nabawy M; Sakr R; el-Hawary MF
    J Egypt Med Assoc; 1968; 51(11):949-63. PubMed ID: 5714513
    [No Abstract]   [Full Text] [Related]  

  • 36. Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy.
    Inoue R; Miyake M; Kanazawa A; Sato M; Kakimoto Y
    Metabolism; 1979 Aug; 28(8):801-4. PubMed ID: 454517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    McKeran RO; Halliday D; Purkiss P
    J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CREATINE IN URINE: ITS DETERMINATION BY MEANS OF CREATINE PHOSPHOKINASE. OBSERVATIONS IN NORMAL MEN AND WOMEN.
    KIBRICK AC
    Clin Chim Acta; 1965 May; 11():408-13. PubMed ID: 14347987
    [No Abstract]   [Full Text] [Related]  

  • 39. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence].
    Pizarro M; Lissi E; Reyes J; Holmgren J
    Rev Med Chil; 1998 Oct; 126(10):1165-72. PubMed ID: 10030087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoaciduria in progressive muscular dystrophy. A family study.
    Beckmann R; Ritter H
    Ger Med Mon; 1967 Feb; 12(2):76-80. PubMed ID: 6044995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.